Literature DB >> 21068277

Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.

Franziska A Stressmann1, Geraint B Rogers, Erich R Klem, Andrew K Lilley, Scott H Donaldson, Thomas W Daniels, Mary P Carroll, Nilesh Patel, Benjamin Forbes, Richard C Boucher, Matthew C Wolfgang, Kenneth D Bruce.   

Abstract

The aim of this study was to determine whether geographical differences impact the composition of bacterial communities present in the airways of cystic fibrosis (CF) patients attending CF centers in the United States or United Kingdom. Thirty-eight patients were matched on the basis of clinical parameters into 19 pairs comprised of one U.S. and one United Kingdom patient. Analysis was performed to determine what, if any, bacterial correlates could be identified. Two culture-independent strategies were used: terminal restriction fragment length polymorphism (T-RFLP) profiling and 16S rRNA clone sequencing. Overall, 73 different terminal restriction fragment lengths were detected, ranging from 2 to 10 for U.S. and 2 to 15 for United Kingdom patients. The statistical analysis of T-RFLP data indicated that patient pairing was successful and revealed substantial transatlantic similarities in the bacterial communities. A small number of bands was present in the vast majority of patients in both locations, indicating that these are species common to the CF lung. Clone sequence analysis also revealed that a number of species not traditionally associated with the CF lung were present in both sample groups. The species number per sample was similar, but differences in species presence were observed between sample groups. Cluster analysis revealed geographical differences in bacterial presence and relative species abundance. Overall, the U.S. samples showed tighter clustering with each other compared to that of United Kingdom samples, which may reflect the lower diversity detected in the U.S. sample group. The impact of cross-infection and biogeography is considered, and the implications for treating CF lung infections also are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068277      PMCID: PMC3020463          DOI: 10.1128/JCM.01650-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  A taxa-area relationship for bacteria.

Authors:  M Claire Horner-Devine; Melissa Lage; Jennifer B Hughes; Brendan J M Bohannan
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

Review 2.  Microbial biogeography: putting microorganisms on the map.

Authors:  Jennifer B Hughes Martiny; Brendan J M Bohannan; James H Brown; Robert K Colwell; Jed A Fuhrman; Jessica L Green; M Claire Horner-Devine; Matthew Kane; Jennifer Adams Krumins; Cheryl R Kuske; Peter J Morin; Shahid Naeem; Lise Ovreås; Anna-Louise Reysenbach; Val H Smith; James T Staley
Journal:  Nat Rev Microbiol       Date:  2006-02       Impact factor: 60.633

3.  The diversity and biogeography of soil bacterial communities.

Authors:  Noah Fierer; Robert B Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

4.  'Everything is everywhere, but, the environment selects'; what did Baas Becking and Beijerinck really say?

Authors:  Rutger de Wit; Thierry Bouvier
Journal:  Environ Microbiol       Date:  2006-04       Impact factor: 5.491

Review 5.  Cystic fibrosis: a polymicrobial infectious disease.

Authors:  Christopher D Sibley; Harvey Rabin; Michael G Surette
Journal:  Future Microbiol       Date:  2006-06       Impact factor: 3.165

6.  A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.

Authors:  Prabhakar Salunkhe; Catherine H M Smart; J Alun W Morgan; Stavroula Panagea; Martin J Walshaw; C Anthony Hart; Robert Geffers; Burkhard Tümmler; Craig Winstanley
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

7.  Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.

Authors:  G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; V Kehagia; G J Connett; K D Bruce
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

8.  Cystic fibrosis mortality and survival in the UK: 1947-2003.

Authors:  J A Dodge; P A Lewis; M Stanton; J Wilsher
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

9.  characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.

Authors:  G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; K D Bruce
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

10.  Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients.

Authors:  Ute Römling; Abdul Kader; Dinesh Diraviam Sriramulu; Roger Simm; Göran Kronvall
Journal:  Environ Microbiol       Date:  2005-07       Impact factor: 5.491

View more
  32 in total

Review 1.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

2.  True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.

Authors:  Vibeke B Rudkjøbing; Trine R Thomsen; Morten Alhede; Kasper N Kragh; Per H Nielsen; Ulla R Johansen; Michael Givskov; Niels Høiby; Thomas Bjarnsholt
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  Mechanical homogenization increases bacterial homogeneity in sputum.

Authors:  Joshua R Stokell; Ammad Khan; Todd R Steck
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

Review 4.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

5.  Single-molecule long-read 16S sequencing to characterize the lung microbiome from mechanically ventilated patients with suspected pneumonia.

Authors:  Ian Toma; Marc O Siegel; John Keiser; Anna Yakovleva; Alvin Kim; Lionel Davenport; Joseph Devaney; Eric P Hoffman; Rami Alsubail; Keith A Crandall; Eduardo Castro-Nallar; Marcos Pérez-Losada; Sarah K Hilton; Lakhmir S Chawla; Timothy A McCaffrey; Gary L Simon
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

6.  ABCs of the lung microbiome.

Authors:  James M Beck
Journal:  Ann Am Thorac Soc       Date:  2014-01

7.  Airway microbiota across age and disease spectrum in cystic fibrosis.

Authors:  Edith T Zemanick; Brandie D Wagner; Charles E Robertson; Richard C Ahrens; James F Chmiel; John P Clancy; Ronald L Gibson; William T Harris; Geoffrey Kurland; Theresa A Laguna; Susanna A McColley; Karen McCoy; George Retsch-Bogart; Kurtis T Sobush; Pamela L Zeitlin; Mark J Stevens; Frank J Accurso; Scott D Sagel; J Kirk Harris
Journal:  Eur Respir J       Date:  2017-11-16       Impact factor: 16.671

8.  Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.

Authors:  Marianne S Muhlebach; Joseph E Hatch; Gisli G Einarsson; Stef J McGrath; Deirdre F Gilipin; Gillian Lavelle; Bojana Mirkovic; Michelle A Murray; Paul McNally; Nathan Gotman; Sonia Davis Thomas; Matthew C Wolfgang; Peter H Gilligan; Noel G McElvaney; J Stuart Elborn; Richard C Boucher; Michael M Tunney
Journal:  Eur Respir J       Date:  2018-07-11       Impact factor: 16.671

9.  Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.

Authors:  Amanda F Goddard; Benjamin J Staudinger; Scot E Dowd; Amruta Joshi-Datar; Randall D Wolcott; Moira L Aitken; Corinne L Fligner; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

Review 10.  The respiratory microbiome of HIV-infected individuals.

Authors:  M B Lawani; A Morris
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.